Neurotoxicity Research

, Volume 12, Issue 1, pp 43–60

Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders

  • Tomas Palomo
  • Richard M. Kostrzewa
  • Richard J. Beninger
  • Trevor Archer
Article

Abstract

Psychiatric disorders may co-occur in the same individual. These include, for example, substance abuse or obsessive-compulsive disorder with schizophrenia, and movement disorders or epilepsy with affective dysfunctional states. Medications may produce iatrogenic effects, for example cognitive impairments that co-occur with the residual symptoms of the primary disorder being treated. The observation of comorbid disorders in some cases may reflect diagnostic overlap. Impulsivity, impulsiveness or impulsive behaviour is implicated in a range of diagnostic conditions including substance abuse, affective disorder and obsessive-compulsive disorder. These observations suggest a need to re-evaluate established diagnostic criteria and disorder definitions, focusing instead on symptoms and symptom-profiles.

Keywords

Treatment Symptoms Obsessive-compulsive Psychosis Comorbidity Schizophrenia Impulsivity Affective Epilepsy Substance abuse Neuropsychiatry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Addington J and D Addington (1998) The effect of substance abuse in early psychosis.Psychiatr. Serv. 49, 925–928.PubMedGoogle Scholar
  2. Akbarian S, JJ Kim, SG Potkinet al. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.Arch. Gen Psychiatry 52, 258–266.PubMedGoogle Scholar
  3. Albanese MJ, EJ Khantzian, SL Murphy and AI Green (1994) Decreased substance use in chronically psychotic patients treated with clozapine [letter].Am. J. Psychiatry 151, 780–781.PubMedGoogle Scholar
  4. Albertson TE, RM Joy and LG Stark (1984) Carbamazepine: a pharmacological study in the kindling model of epilepsy.Neuropharmacology 23, 1117–1124.PubMedCrossRefGoogle Scholar
  5. Allcock CC and DM Grace (1988) Pathological gamblers are neither impulsive nor sensation-seekers.Aust. NZ J. Psychiatry 22, 307–311.CrossRefGoogle Scholar
  6. Allen TJ, EG Moeller, HM Rhoades and DR Cherek (1998) Impulsivity and history of drug dependence.Drug Alcohol Depend. 50, 137–145.PubMedCrossRefGoogle Scholar
  7. Anderson SW, A Bechara, H Damasio, D Tranel and AR Damasio (1999) Impairment of social and moral behaviour related to early damage in human prefrontal cortex.Nat. Neurosci. 2, 1032–1037.PubMedCrossRefGoogle Scholar
  8. Archer T, G Jonsson, BG Minor and C Post (1986) Noradrenergic-serotonergic interactions and nociception in the rat.Eur. J. Pharmacol. 120, 295–307.PubMedCrossRefGoogle Scholar
  9. Askenazy FL, K Sorci, M Benoit, K Lestideau, M Myquel and Y Lecrubier (2003) Anxiety and impulsivity levels identify relevant subtypes in adolescents with at-risk behaviour.J. Affect. Disord. 74, 219–227.PubMedCrossRefGoogle Scholar
  10. Ball SA (2001) Reconceptualizing personality disorder categories using personality trait dimensions: introduction to special section.J. Personal. 69, 147–153.CrossRefGoogle Scholar
  11. Ball SA, H Tennen, JC Poling, HR Kranzler and BJ Rounsaville (1997) Personality, temperament and character dimensions in substance abusers.J. Abnorm. Psychol. 106, 545–553.PubMedCrossRefGoogle Scholar
  12. Barratt ES (1965) Factor analysis of some psychometric measures of impulsiveness and anxiety.Psychol. Rev. 16, 547–554.Google Scholar
  13. Barratt ES (1985) Impulsiveness subtraits: arousal and information processing, In:Motivation, Emotion and Personality (Spence JT and CE Izard, Eds.) (Elsevier: New York), pp. 137–143.Google Scholar
  14. Barratt ES and J Patton (1983) Impulsivity: cognitive, behavioral and psychophysiological correlates, In:Biological Bases of Impulsivity and Sensation Seeking (Zuckerman M, Ed.) (Erlbaum: Hillsdale, NJ), pp. 77–122.Google Scholar
  15. Barratt ES, MS Stanford, TA Kent and A Felthous (1997) Neuropsychological and cognitive psychophysiological substrates of impulsive aggression.Biol. Psychiatry 41, 1045–1061.PubMedCrossRefGoogle Scholar
  16. Barrowclough C (2007) Co-morbid psychosis and substance abuse, In:Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebroy Mente: Madrid) (in press).Google Scholar
  17. Bastani B, RC Arora and HY Meltzer (1991) Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive patients.Biol. Psychiatry 30, 131–139.PubMedCrossRefGoogle Scholar
  18. Bechara A, H Damasio and D Tranel (1997) Deciding advantageously before knowing the advantageous strategy.Science 275, 1293–1295.PubMedCrossRefGoogle Scholar
  19. Beninger RJ (2006) Dopamine and incentive learning: a framework for considering antipsychotic medication effects.Neurotox. Res. 10, 1–11.Google Scholar
  20. Beninger RJ, JI Wassreman, K Zanibbi, D Charbonneau, J Mangels and BV Beninger (2003) Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation.Schizophr. Res. 61, 281–292.PubMedCrossRefGoogle Scholar
  21. Berlin HA, ET Rolls and U Kischka (2004) Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions.Brain 127, 1108–1126.PubMedCrossRefGoogle Scholar
  22. Blair RJR (1995) A cognitive developmental approach to mortality: investigating the psychopathy.Cognition 57, 1–29.PubMedCrossRefGoogle Scholar
  23. Blair RJR (2001) Neuro-cognitive models of aggression, the antisocial personality disorders and psychopathy.J. Neurol. Neurosurg. Psychiatry 71, 727–731.PubMedCrossRefGoogle Scholar
  24. Blair RJR (2003) Neurobiological basis of psychopathy.Br. J. Psychiatry 182, 5–7.PubMedCrossRefGoogle Scholar
  25. Blair RJ, JS Morris, CD Frith, DI Perrett and RJ Dolan (1999) Dissociable neural responses to facial expressions of sadness and anger.Brain 122, 883–893.PubMedCrossRefGoogle Scholar
  26. Blanco C, L Orensanz-Munoz, C Blanco-Jerez and J Saiz-Ruiz (1996) Pathological gambling and platelet MAO activity: a psychobiological study.Am. J. Psychiatry 153, 119–121.PubMedGoogle Scholar
  27. Blaszczynski AP, Z Steel and N McConaghy (1997) Impulsivity in pathological gambling: the antisocial impulsivist.Addiction 92, 75–87.PubMedCrossRefGoogle Scholar
  28. Bolwig (2007) Epilepsy and affective disorder: clinical manifestations and pathophysiological considerations, In:Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebroy Mente: Madrid) (in press).Google Scholar
  29. Bond AJ, SL Verheyden, J Wingrove and HV Curran (2004) Angry cognitive bias, trait aggression and impulsivity in substance users.Psychopharmacology 171, 331–339.PubMedCrossRefGoogle Scholar
  30. Bood S-Å, T Archer and T Norlander (2004) Affective personality in relation to general personality, self-reported stress, coping and optimism.Ind. Diff. Res. 2, 26–37.Google Scholar
  31. Borsini F and A Meli (1988) Is the forced swimming test a suitable model for revealing antidepressant activity.Psychopharmacology 94, 147–160.PubMedCrossRefGoogle Scholar
  32. Braak H and E Braak (1991) Neuropathological stageing of Alzheimer-related changes.Acta Neuropathol. 82, 239–259.PubMedCrossRefGoogle Scholar
  33. Brady KT, H Myrick and S McElroy (1998) The relationship between substance abuse disorders, impulse control disorders, and pathological aggression.Am. J. Addict. 7, 221–230.PubMedCrossRefGoogle Scholar
  34. Brent DA, BA Johnson, J Perper, J Connolly, J Bridge, S Bartle and C Rather (1994) Personality disorder, personality traits, impulsive violence, and completed suicide in adolescents.J. Am. Acad. Child Adolesc. Psychiatry 33, 1080–1086.PubMedGoogle Scholar
  35. Carlton PL and P Manowitz (1994) Factors affecting the severity of pathological gamblers in males.J. Gambling Stud. 10, 147–157.CrossRefGoogle Scholar
  36. Castellani B and L Rugle (1995) A comparison of pathological gamblers to alcoholics and cocaine misusers on impulsivity, sensation-seeking, and craving.Int. J. Addict. 30, 275–289.PubMedGoogle Scholar
  37. Cavedini P, G Riboldi, R Keller, A D/rsAnnucci and L Bellodi (2002) Frontal lobe dysfunction in pathological gambling patients.Biol. Psychiatry 51, 334–341.PubMedCrossRefGoogle Scholar
  38. Chambers RA, JR Taylor and MN Potenza (2003) Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.Am. J. Psychiatry 160, 1041–1052.PubMedCrossRefGoogle Scholar
  39. Cloninger CR (1999)Temperament and Character Inventory —Revised (St. Louis Center for Psychology of Personality, Washington University: St. Louis, MO).Google Scholar
  40. Cloninger CR, DM Svrakic and TR Przybeck (1993) A psychobiological model of temperament and chatracter.Arch. Gen. Psychiatry 50, 975–990.PubMedGoogle Scholar
  41. Coccaro EF (1989) Central serotonin and impulsive aggression.Br. J. Psychiatry 155, 52–62.Google Scholar
  42. Combs DR and C Advocat (2000) Antipsychotic medication and smoking prevalence in acutely hospitalised patients with chronic schizophrenia.Schizophr. Res. 24, 129–137.CrossRefGoogle Scholar
  43. Convit A, P Czober and J Volavka (1991) Lateralized abnormality in the EEG of persistently violent psychiatric inpatients.Biol. Psychiatry 3, 121–138.Google Scholar
  44. Cools R, A Blackwell, L Clark, L Menzies, S Cox and TW Robbins (2005) Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity.Neuropsychopharmacology 30, 1362–1373.PubMedGoogle Scholar
  45. Corruble E, C Damy and JD Guelfi (1999) Impulsivity: a relavant dimension in depression regarding suicide attempts?J. Affect. Disord. 53, 211–215.PubMedCrossRefGoogle Scholar
  46. Corruble E, A Benyamina, F Bayle, B Falissard and P Hardy (2003) Understanding impulsivity in severe depression? A psychometrical contribution.Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 829–833.PubMedCrossRefGoogle Scholar
  47. Coyle JT (2006) Substance use disorders and schizophrenia: a question of shared glutamatergic mechanisms.Neurotox Res. 10(3–4), 221–233. Review.PubMedGoogle Scholar
  48. Curtis VA, ET Bullmore, RG Morriset al. (1999) Attenuated frontal activation in schizophrenia may be task dependent.Schizophr. Res. 37, 35–44.PubMedCrossRefGoogle Scholar
  49. Dalack GW and JH Meador-Woodruff (1996) Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature.Schizophr. Res. 22, 133–141.PubMedCrossRefGoogle Scholar
  50. Dalack GW, DJ Healy and JH Meador-Woodruff (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.Am. J. Psychiatry 155, 1490–1501.PubMedGoogle Scholar
  51. Dalack GW, L Becks, E Hill, OF Pomerleau and JH Meador-Woodruff (1999) Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.Neuropsychopharmacol.21, 195–202.CrossRefGoogle Scholar
  52. DeCaria CM, E Hollander, R Grossman, CM Wong, SA Mosivich and S Cherkasky (1996) Diagnosis, neurobiology, and treatment of pathological gamblers.J. Clin. Psychiatry 57 (Suppl. 8), 80–84.PubMedGoogle Scholar
  53. De Haan L, J Booij, J Lavalaye, T van Amelsvoort and D Linszen (2006) Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients.Psychopharmacology 183, 500–505.PubMedCrossRefGoogle Scholar
  54. Dikman ZV and JJ Allen (2000) Error monitoring during reward and avoidance learning in high- and low-socialized individuals.Psychophysiology 37, 43–54.PubMedCrossRefGoogle Scholar
  55. Dolan M, WJF Deakin, N Roberts and I Anderson (2002) Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are their implications for treatment?Psychol. Med. 32, 105–117.PubMedGoogle Scholar
  56. Dougherty DM, JM Bjork, HC Huckabee, FG Moeller and AC Swann (1999) Laboratory measures of aggression and impulsivity in women with borderline personality disorder.Psychiatry Res. 85, 315–326.PubMedCrossRefGoogle Scholar
  57. Dougherty DM, JM Bjork, RA Harper, DM Marsh, FG Moeller, CW Mathias and AC Swann (2003) Behavioral impulsivity paradigms: a comparason in hospitalized adolescents with disruptive behavior disorders.J. Child Psychol. Psychiatry 44, 1145–1157.PubMedCrossRefGoogle Scholar
  58. Drake ME, SA Hietter and A Pakalnis (1992) EEG and evoked potentials in episodic dyscontrol syndrome.Neuropsychobiol. 26, 125–128.CrossRefGoogle Scholar
  59. Drake RE, KT Mueser, MF Brunette and GJ McHugo (2004) A review of treatments for people with severe mental illnesses and co-occuring substance abuse disorders.Psychiatr. Rehabil. J. 27, 360–374.PubMedCrossRefGoogle Scholar
  60. Drevets WC, JL Price, ME Bardgett, T Reich, RD Todd and ME Raichle (2002) Glucose metabolism in the amygdale in depression: relationship to diagnostic subtype and plasma cortisol levels.Pharmacol. Biochem. Behav. 71, 431–447.PubMedCrossRefGoogle Scholar
  61. Dupin N, F Mailliet, C Rocher, K Kessal, M Spedding and TM Jay (2006) Common efficacy of psychotropic drugs in restoring stress-induced impairment of prefrontal plasticity.Neurotox. Res. 10(3,4), 193–198.PubMedGoogle Scholar
  62. Eisen JL, DA Beer, MT Pato, TA Venditto and SA Rasmussen (1997) Obsessive-compulsive disorder in patients with schizophrenia and schizoaffective disorder.Am. J. Psychiatry 154, 271–273.PubMedGoogle Scholar
  63. Ekselius L, E Lindström, L Von Knorring and O Bondulund (1994) Comorbidity among the personality disorders in DSM-IIIR. Pers.Individ. Differ. 17, 545–553.CrossRefGoogle Scholar
  64. Els C (2004) What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?J. Psychiatry Neurosci. 29, 240–244.PubMedGoogle Scholar
  65. Evenden JL (1999) Varieties of impulsivity.Psychopharmacology 146, 348–361.PubMedCrossRefGoogle Scholar
  66. Farrington DP (1997) The relationship between low resting heart rate and violence, In:Biological Bases of Violence (Raine A, PA Brennan, DP Farrington and SA Mednick, Eds.) (Plenum: New York), pp. 89–105.Google Scholar
  67. Fawcett J, KA Busch, D Jacobs, HM Kravitz and L Fogg (1997) Suicide: a four-pathway clinical-biochemical model.Ann. NY Acad. Sci. 836, 288–301.PubMedCrossRefGoogle Scholar
  68. Finberg JP, I Lamensdorf, JW Commissiong and MBH Youdim (1996) Pharmacology and neuroprotective properties of rasagiline.J. Neural Transm. Suppl.48, 95–101.Google Scholar
  69. Fishbein DH, RJ Herning, WB Pickworth, CA Haertzen, JE Hickey and JH Jaffe (1989) EEG and brainstem auditory evoked response potentials in adult male drug abusers with self-reported histories of aggressive behaviour.Biol. Psychiatry 25, 595–611.CrossRefGoogle Scholar
  70. Fletcher PC, F Happe, U Frith, SC Baker, RJ Dolan, RS Frackowiak and CD Frith (1995) Other minds in the brain: a functional imaging study of “theory of mind” in story comprehension.Cognition 57, 109–128.PubMedCrossRefGoogle Scholar
  71. Fossati A, C Maffei, M Bagnato, M Battaglia, D Donati and M Donini (2000) Patterns of covariation of DSM-IV personality disorders in a mixed psychiatry sample.Comprehen. Psychiatry 41, 206–215.CrossRefGoogle Scholar
  72. Fossati A, A Di Ceglie, E Acquarini and ES Barratt (2001) Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in non-clinical subjects.J. Clin. Psychol. 57, 815–828.PubMedCrossRefGoogle Scholar
  73. Fossati A, C Maffei, E Acquarini and A Di Ceglie (2003) Multi-group confirmatory component and the factor analyses of Italian version of the Aggression Questionaire.Eur. J. Psychol. Assess. 19, 54–65.CrossRefGoogle Scholar
  74. Fossati A, ES Barratt, S Borroni, D Villa, F Grazioli and C Maffei (2006) Impulsivity, aggressiveness, and DSM-IV personality disorders.Psychiatry Res. 149(1–3), 157–167. Epub 2006 Dec 8.PubMedGoogle Scholar
  75. Fuentes D, H Tavares, R Artes and C Gorenstein (2006) Self-reported and neuropsychological measures of impulsivity in pathological gambling.J. Int. Neuropsycholog. Soc. 12, 907–912.Google Scholar
  76. Gabbard GO (2005) Mind, brain, and personality disorders.Am. J. Psychiatry 162, 648–655.PubMedCrossRefGoogle Scholar
  77. Gal S, H Zheng, M Fridkin and MBH Youdim (2005) Novel multifunctional neuroprotective chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases.In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion.J. Neurochem. 95, 79–88.PubMedCrossRefGoogle Scholar
  78. Gatzke-Kopp LM, A Raine, R Loeber, M Strouthamer and S Steinhauer (2002) Serious delinquent behavior, sensation seeking and electrodermal arousal.J. Abnorm. Child Psychol. 30, 477–486.PubMedCrossRefGoogle Scholar
  79. Gehring WJ and AR Willoughby (2002) The medial frontal cortex and the rapid processing of monetary gains and losses.Science 295, 2279–2282.PubMedCrossRefGoogle Scholar
  80. Gehring WJ, J Himle and LG Nisenson (2000) Action-monitoring dysfunction in obsessive-compulsive disorder.Psychol. Sci. 11, 1–6.PubMedCrossRefGoogle Scholar
  81. George TP, DM Ziedonis, A Feingold, WT Pepper, CA Satterburg, J Winkel, BJ Rounsaville and TR Kosten (2000) Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in patients with schiziphrenia.Am. J. Psychiatry 157, 1835–1842.PubMedCrossRefGoogle Scholar
  82. Gerstle JE, CW Mathias and MS Stanford (1998) Auditory P300 and self-reported impulsive aggression.Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22, 575–583.CrossRefGoogle Scholar
  83. Geyer MA (2006) The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?Neurotox. Res. 10, 1–10.Google Scholar
  84. Goma-i-Freixanet M (1995) Prosocial and antisocial aspects of personality.Pers. Individ. Differ. 19, 125–134.CrossRefGoogle Scholar
  85. Gong L, RM Kostrzewa, RW Fuller and KW Perry (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system.J. Pharmacol. Exp. Ther. 261, 1000–1007.PubMedGoogle Scholar
  86. Gong L, RM Kostrzewa, KW Perry and RW Fuller (1993) Dose-related effects of a neonatal 6-OHDA lesion on SKF-38393- and m-chlorophenylpiperazine-induced oral activity responses of rats.Dev. Brain Res. 76, 233–238.CrossRefGoogle Scholar
  87. Goveas JS, JG Csermansky and EF Coccaro (2004) Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects.Psychiatr. Res. 126, 23–32.CrossRefGoogle Scholar
  88. Green AI (2006) Pharmacotherapy for schizophrenia and co-occuring substance abuse disorders.Neurotox. Res. 11, 1–7.Google Scholar
  89. Green AI, MS Salomon, MJ Brenner and K Rawlins (2002) Treatment of schizophrenia and comorbid substance use disorder.Curr. Drug Targets CNS Neurol. Disord. 1, 129–139.PubMedCrossRefGoogle Scholar
  90. Green AI, ES Burgess, R Dawson, SV Zimmet and RD Strous (2003) Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.Schizophr. Res. 60, 81–85.PubMedCrossRefGoogle Scholar
  91. Green AI, MF Tohen, RM Hamer, SM Strakowski, JA Lieberman, I Glick, WS Clark and the HGDH Research Group (2004) First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.Schizophr. Res. 66, 125–135.PubMedCrossRefGoogle Scholar
  92. Gualtieri CT (1995) The contribution of the frontallobes to a theory of psychopathology, In:Neuropsychiatry of Personality Disorders (Racey JJ, Ed.) (Blackwell: Cambridge, UK).Google Scholar
  93. Hare RD (1978) Electrodermal and cardiovascular correlates of psychopathy, In:Psychopathic Behavior Approaches to Research (Hare RD and D Schalling, Eds.) (Wiley: New York), pp. 107–144.Google Scholar
  94. Hare RD (1991)The Hare Psychopathy Checklist—Revised (Multi-Health Systems: Toronto, Ontario).Google Scholar
  95. Hare RD, DJ Cooke and SD Hart (1999) Psychopathy and sadistic personality disorder, In:Oxford Textbook of Psychopathology (Millon T, PH Blaney and RD Davis, Eds.) (Oxford Univ. Press: London), pp. 555–584.Google Scholar
  96. Hart SD and RD Hare (1996) Psychopathy and antisocial personality disorder.Curr. Opin. Psychiatry 9, 129–132.CrossRefGoogle Scholar
  97. Harvey PD, MH Serper, L White, MJ Parrella, SR McGurk, PJ Moriarty, C Bowie, N Vadhan, J Friedman and KL Davis (2001) The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.Compr. Psychiatry 42, 306–313.PubMedCrossRefGoogle Scholar
  98. Haustein KO, S Haffner and BG Woodcock (2002) A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients.Int. J. Clin. Pharmacol. Ther. 40, 404–418.PubMedGoogle Scholar
  99. Heckers S, SL Rauch, D Goff, CR Savage, DL Schacter, AJ Fischman and NM Alpert (1998) Impaired recruitment of the hippocampus during conscious recollection in schizophrenia.Nat. Neurosci. 1, 318–323.PubMedCrossRefGoogle Scholar
  100. Herran A, A de Santiago, M Sandoya, MJ Fernandez, JF Diez-Manrique and JL Vazquez-Barquero (2000) Determinants of smoking behaviour in outpatients with schizophrenia.Schizophr. Res. 41, 373–381.PubMedCrossRefGoogle Scholar
  101. Hester R and H Garavan (2004) Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity.J. Neurosci. 24, 11017–11022.PubMedCrossRefGoogle Scholar
  102. Hodgson RJ and S Rachman (1977) Obsessional-compulsion complaints.Behav. Res. Ther. 15, 389–395.PubMedCrossRefGoogle Scholar
  103. Hoehn-Saric R and VC Barksdale (1983) Impulsiveness in obsessive-compulsive patients.Br. J. Psychiatry 143, 177–182.PubMedCrossRefGoogle Scholar
  104. Hollander E and CM Wong (1995) Obsessive-compulsive spectrum disorders.J. Clin. Psychiatry 56(Suppl. 4), 3–6.PubMedGoogle Scholar
  105. Hollander E, JH Kwon, DJ Stein, J Broatch, CT Rowland and CA Himelein (1996) Obsessive-compulsive spectrum disorders: overview and quality of life issues.J. Clin. Psychiatry 57(Suppl. 8), 3–6.PubMedGoogle Scholar
  106. Hoptman MJ, J Volavka, G Johnson, E Weiss, RM Bilder and KO Lim (2002) Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study.Biol. Psychiatry 52, 9–14.PubMedCrossRefGoogle Scholar
  107. Horesh N (2001) Self-report vs. computerised measures of impulsivity as a correlate of suicidal behavior.Crisis 22, 27–31.PubMedGoogle Scholar
  108. Horn NR, M Dolan, R Elliott, JF Deakin and PW Woodruff (2003) Response inhibition and impulsivity: an fMRI study.Neuropsychologia 41, 1959–1966.PubMedCrossRefGoogle Scholar
  109. Houston RJ and MS Stanford (2001) Mid-latency evoked potential in self-reported impulsive aggression.Int. J. Psychophysiol. 40, 1–15.PubMedCrossRefGoogle Scholar
  110. Houston RJ and MS Stanford (2005) Electrophysiological substrates of impulsiveness: potential effects on aggressive behavior.Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29, 305–313.CrossRefGoogle Scholar
  111. Huang N-Y and RM Kostrzewa (1994) Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopaminelesioned rats.Eur. J. Pharmacol. 253, 163–166.PubMedCrossRefGoogle Scholar
  112. Huang N-Y, RM Kostrzewa, C Li, KW Perry and RW Fuller (1997) Increased spontaneous oral dyskinesias persist in haloperidol-withdrawn rats neonatally lesioned with 6-hydroxydopamine: absence of an association with the Bmax for [3H]raclopride binding to neostriatal homogenates.J. Pharmacol. Exp. Ther. 280, 268–276.PubMedGoogle Scholar
  113. Huang W, Y Chen, E Shohami and M Weinstock (1999) Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.Eur. J. Pharmacol. 366, 127–135.PubMedCrossRefGoogle Scholar
  114. Jobe PC, JW Dailey and JF Wernicke (1999) A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders.Crit. Rev. Neurobiol. 13, 317–356.PubMedGoogle Scholar
  115. Kamali M, MA Oquendo and JJ Mann (2001) Understanding the neurobiology of suicidal behaviour.Depress. Anxiety 14, 164–176.PubMedCrossRefGoogle Scholar
  116. Kanner AM and A Balabanov (2002) Depression and epilepsy. How closely related are they?Neurology 58(Suppl. 5), S27-S39.PubMedGoogle Scholar
  117. Kanner AM and S Palac (2000) Depression in epilepsy: a common but often unrecognized maladie.Epilepsy Behav. 1, 37–51.PubMedCrossRefGoogle Scholar
  118. Karilampi U, L Helldin, F Hjärthag, T Norlander and T Archer (2007) Verbal learning in schizopsychotic outpatients as a function of cognitive performance levels.Arch. Clin. Neuropsychol. 2007 Jan 20; [Epub ahead of print].Google Scholar
  119. Karlsson E and T Archer (2007a) Relationship between personality characteristics and affect: gender and affective personality.Individ. Differ. Res. (In press).Google Scholar
  120. Karlsson E and T Archer (2007b) Affective state, stress and Type A-personality as a function of gender and affective personality.Pers Soc. Psychol. (In press).Google Scholar
  121. Kashden J, WJ Fremouw, TS Callahan and MD Franzen (1993) Impulsivity in suicidal and nonsuicidal adolescents.J. Abnorm. Child Psychol. 21, 339–353.PubMedCrossRefGoogle Scholar
  122. Keilp JG, HA Sackeim, BS Brodsky, MA Oquendo, KM Malone and JJ Mann (2001) Neuropsychological dysfunction in depressed suicide attempters.Am. J. Psychiatry 158, 735–741.PubMedCrossRefGoogle Scholar
  123. Kiehl KA, AM Smith, RD Hare, A Mendrek, BB Forster, J Brink and PF Liddle (2001) Limbic abnormalities in affective processing by criminal psychopaths as revealed by functional magnetic resonance imaging.Biol. Psychiatry 50, 677–684.PubMedCrossRefGoogle Scholar
  124. Knowton BJ, JA Mangels and LR Squire (1996) A neostriatal habit learning system in humans.Science 273, 1399–1402.CrossRefGoogle Scholar
  125. Kostrzewa RM (1995) Dopamine receptor supersensitivity.Neurosci. Biobehav. Rev. 19, 1–17.PubMedCrossRefGoogle Scholar
  126. Kostrzewa RM, N-Y Huang, JP Kostrzewa, P Nowak and R Brus (2007) Modeling tardive dyskinesia: predictive 5-HT(2C) receptor antagonist treatment.Neurotox. Res. 11, 41–50.PubMedGoogle Scholar
  127. Krochmalik A, MK Jones and RG Menzies (2001) Danger Ideation Reduction Therapy (DIRT) for treatment-resistent compulsive washing.Behav. Res. Ther. 39, 897–912.PubMedCrossRefGoogle Scholar
  128. Kruger S, P Braunig, J Hoffer, G Shugar, I Bommer and J Langkrar (2000) Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms.J. Neuropsychiatr. Clin. Neurosci. 12, 16–24.Google Scholar
  129. Krystal JH, DC D/rsSouza, J Gallinat, N Driesen, A Abi-Dargham, I Petrakis, A Heinz and G Pearlson (2006) The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.Neurotox Res. 10(3,4), 235–252. Review.PubMedGoogle Scholar
  130. Lacey JH and CDH EVans (1986) The impulsivist: a multiimpulsive personality disorder.Br. J. Addict. 81, 641–649.PubMedCrossRefGoogle Scholar
  131. Lahey BB, K McBurnett, R Loeber and EL Hart (1995) Psychobiology, In:Conduct Disorders in Children and Adults (Sholevar G, Ed.) (Am. Psychiatr. Press: Washington), pp. 27–44.Google Scholar
  132. LaPierre D, CMJ Braun and S Hodgins (1995) Ventral frontal deficits in psychopathy: neuropsychological test findings.Neuropsychologia 33, 139–151.PubMedCrossRefGoogle Scholar
  133. Leentjens AF (2004) Depression in Parkinson’s disease: conceptual issues and clinical challenges.J. Geriatr. Psychiatry Neurol. 17, 120–126.PubMedCrossRefGoogle Scholar
  134. Lejoyeux M, M Arbaretaz, M McLoughlin and J Ades (2002) Impulse control disorders and depression.J. Nerv. Ment. Disord. 190, 310–314.CrossRefGoogle Scholar
  135. Li CR and S-H Chen (2006) Obsessive-compulsiveness and impulsivity in a non-clinical population of adolescent males and females.Psychiatr. Res. (In press).Google Scholar
  136. Links PS, R Heslegrave and R van Reekum (1999) Impulsivity: core aspect of borderline personality disorder.J. Pers. Disord. 13, 1–9.PubMedGoogle Scholar
  137. Lish JD, RJ Kavoussi and EF Coccaro (1996) Aggressiveness, In:Personality Characteristics of the Personality Disordered (Costello CG, Ed.) (Wiley: New York), pp. 24–47.Google Scholar
  138. Lobo A, P Saz, G Marcos, R Campos, J Garcia-Campayo, F Orozco, M Barcones, A Capayo and A Sarasola (2005) Depressive co-morbidity in medical in-patients at the time of hospital discharge and outcome in a primary care follow-up. I Rational and design of the project.Eur. J. Psychiatry 19.Google Scholar
  139. Lobo A, P Saz, G Marcos, A Sarasola, MF Barcones, A Bulbena, J De Pablo, JM Farréet al (2007) Depressive comorbidity in patients with somatic pathology, In:Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebro y Mente: Madrid) (In press).Google Scholar
  140. Lykken D (1995)The Antisocial Personalities (Erlbaum: Hillsdale, NJ).Google Scholar
  141. Lysaker PH, KA Marks, JB Picone, AI Rollins, PS Fastenau and GR Bond (2000) Obsessive and compulsive symptoms in schizophrenia. Clinical and neurocognitive correlates.J. Nerv. Ment. Dis. 188, 78–83.PubMedCrossRefGoogle Scholar
  142. Mann JJ (2003) Neurobiology of suicidal behavior.Nat. Rev. Neurosci. 4, 819–828.PubMedCrossRefGoogle Scholar
  143. Martins SS, H Tavares, DS da Silva Lobo, AM Galetti and V Gentil (2004) Pathological gambling, gender, and risk-taking behaviors.Addict. Behav. 29, 1231–1235.PubMedCrossRefGoogle Scholar
  144. Maser JD, HS Akiskal, P Schettler, W Scheftner, T Mueller, J Endicott, D Solomon and P Clayton (2002) Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behavior? A 14-prospective study.Suicide Life-Threat. Behav. 32, 10–32.PubMedCrossRefGoogle Scholar
  145. Maslin J (2003) Substance misuse in psychosis: contextual issues, In:Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery (Graham H, A Copello, MJ Birchwood and K Mueser, Eds.), (Wiley: Chichester), pp. 108–126.Google Scholar
  146. Mathias CW and MS Stanford (1999) P300 under standard and surprise conditions in self-reported impulsive aggression.Prog. Neuro-Psychopharmacol. Biol. Psychiatry 23, 1037–1051.CrossRefGoogle Scholar
  147. Mathias CW and MS Stanford (2003) Impulsiveness and arousal: heart rate under conditions of rest and challenge in healthy males.Pers. Individ. Differ. 35, 355–371.CrossRefGoogle Scholar
  148. Matsunaga H, N Kiriike, T Matsui, K Oya, K Okino and DJ Stein (2005) Impulsive disorders in Japanese adult patients with obsessive-compulsive disorder.Compr. Psychiatry 46, 43–49.PubMedCrossRefGoogle Scholar
  149. McCormick RA, J Taber, N Kruedelbach and A Russo (1987) Personality profiles of hospitalized pathological gamblers.J. Clin. Psychol. 43, 521–527.PubMedCrossRefGoogle Scholar
  150. McCreadie RG (2002) Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study.Br. J. Psychiatry 181, 321–325.PubMedCrossRefGoogle Scholar
  151. McDonald WM, IH Richard and MR DeLong (2003) Prevalence, etiology, and treatment of depression in Parkinson’s disease.Biol. Psychiatry 54, 363–375.PubMedCrossRefGoogle Scholar
  152. McElroy SL, KA Phillips and PE Keck (1994) Obsessive compulsive spectrum disorder.J. Clin. Psychiatry 55 (Suppl. 10), 33–51.PubMedGoogle Scholar
  153. McEnroy SL, HG Pope, PE Keck and JI Hudson (1995) Disorders of impulsive control, In:Impulsivity and Aggression (Hollander E and D Stein, Eds.) (John Wiley and Sons: Sussex, UK), pp. 109–136.Google Scholar
  154. Mehler-Wex C, P Riederer and M Gerlach (2006) Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder.Neurotox. Res. 10, 167–179, 2006.PubMedGoogle Scholar
  155. Millet P (2005) Locus of control and its relation to working life: studies from the fields of vocational rehabilitation and small firms in Sweden.Doktorsavhandling, Arbetslivsinstitut, Luleås Tekniska Universitet [Doctoral Dissertation, Work Life Institute, Luleå Technical University].Google Scholar
  156. Millet P and K Sandberg (2003) Locus of control and its relationship with rehabilitation outcomes of unemployed sick leavers in Sweden.J. Vocation. Rehab. 19, 59–66.Google Scholar
  157. Moeller FG, ES Barratt, DM Dougherty, JM Schmitz and AC Swann (2001) Psychiatry aspects of impulsivity.Am. J. Psychiatry 158, 1783–1793.PubMedCrossRefGoogle Scholar
  158. Moeller FG, ES Barratt, CJ Fischer, DM Dougherty, EL Reilly, CW Mathias and AC Swann (2004) P300 event-related potential amplitude and impulsivity in cocaine-dependent subjects.Neuropsychobiol. 50, 167–173.CrossRefGoogle Scholar
  159. Molina V (2007) Atypical effects of atypicals in schizophrenia, In:Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebro y Mente: Madrid) (in press).Google Scholar
  160. Molina V, S Reig, M Desco, JD Gispert, J Sanz, F Sarramea, J Pascau, C Benito, R Martinez-Lazaro, R Luque, M Aragues, JM Misiego, IL Corral and T Palomo (2002) Multimodality neuroimaging studies and the neurodevelopmental hypothesis of schizophrenia.Neurotox. Res. 4, 437–451.PubMedCrossRefGoogle Scholar
  161. Molina V, JD Gispert, S Reig, J Sanz, J Pascau, A Santos, T Palomo and M Desco (2003) Cerebral metabolism and risperidone treatment in schizophrenia.Schizophr. Res. 60, 1–7.PubMedCrossRefGoogle Scholar
  162. Molina V, JD Gispert, S Reig, J Pascau, R Martinez, J Sanz, T Palomo and M Desco (2005a) Olanzapine-induced cerebral metabolic changes. Relation to symptom changes in schizophrenia.Int. Clin. Psychopharmacol. 20, 13–18.PubMedCrossRefGoogle Scholar
  163. Molina V, JD Gispert, S Reig, J Pascau, A Santos, M Desco and T Palomo (2005b) Cerebral metabolic changes induced by clozapine in schizophrenia.Psychopharmacology 178, 17–26.PubMedCrossRefGoogle Scholar
  164. Molina V, F Sarramea, J Sanz, C Benito and T Palomo (2005c) Prefrontal atrophy in first episodes of schizophrenia associated with limbic hyperactivity.J. Psychiatr Res. 39, 117–127.PubMedCrossRefGoogle Scholar
  165. Molina V, S Reig, J Sanz, T Palomo, C Benito, J Sanchez, F Sarramea, J Pascau and M Desco (2005d) Increase in grey matter volume and decrease in white matter volume in the cerebral cortex during treatment with atypical neuroleptics in schizophrenia.Schizophr. Res. 80(1), 61–71.PubMedCrossRefGoogle Scholar
  166. Monterosso J and G Ainslie (1999) Beyond discounting: possible experimental models of impulse control.Psychopharmacol. 146, 339–347.CrossRefGoogle Scholar
  167. Morgan MJ, LC Impallomeni, A Pirona and RD Rogers (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drugnaive controls.Neuropsychopharmacol. 31, 1562–1573.CrossRefGoogle Scholar
  168. Mori T, T Sasaki, A Iwanami, T Araki, K Mizuno, T Kato and N Kato (2003) Smoking habits in Japanese patients with schizophrenia.Psychiatr. Res. 120, 207–209.CrossRefGoogle Scholar
  169. Muller JL, M Sommer, V Wagner, K Lange, H Taschler, CH Röder, G Schuierer, HE Klein and G Hajak (2003) Abnormalities in emotion processing within cortical and subcortical regions in criminal psychopaths: evidence from a functional magnetic resonance imaging study using pictures with emotional content.Biol. Psychiatry 54, 152–162.PubMedCrossRefGoogle Scholar
  170. Muller N, A Putz, N Kathmann, R Lehle, W Gunther and A Straube (1997) Characteristics of obsessive-compulsives symptoms in Tourette’s syndrome, obsessive-compulsive disorder and Parkinson’s disease.Psychiatr. Res. 70, 105–114.CrossRefGoogle Scholar
  171. Navas Collado E and JJ Munoz Garcia (2004) Disexecutive syndrome in psychopathy.Revista de Neurologia 38, 582–590.PubMedGoogle Scholar
  172. Nordin C and T Eklundh (1999) Altered CSF 5-HIAA disposition in pathologic male gamblers.CNS Spectrums 4, 25–33.PubMedGoogle Scholar
  173. Norlander T, S-A Bood and T Archer (2002) Performance during stress: affective personality, age, and regularity of physical exercise.Soc. Behav. Personal. Int. J. 30, 495–508.CrossRefGoogle Scholar
  174. O/rsBrien CP, DS Charney, L Lewis, JW Cornish, RM Post, GE Woody, JK Zubieta, JC Anthony, JD Blaineet al. (2004) Priority actions to improve the care of persons with cooccuring substance abuse and other mental disorders: a call to action.Biol. Psychiatry 56, 703–713.CrossRefGoogle Scholar
  175. O/rsGorman JG and JEM Lloyd (1987) Extraversion, impulsiveness and EEG alpha activity.Pers. Individ. Differ. 8, 169–174.CrossRefGoogle Scholar
  176. Palomo T, RJ Beninger, RM Kostrzewa and T Archer (2004) Gene-environment interplay in affect and dementia: emotional modulation of cognitive expression in personal outcomes.Neurotox. Res. 6, 159–173.PubMedCrossRefGoogle Scholar
  177. Paquet E, JP Soucy, E Stip, M Levesque, A Elie and MA Bedard (2004) Ccomparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D-2 receptor occupancy in schizophrenia.J Neuropsychiatr. Clin. Neurosci. 16, 47–56.Google Scholar
  178. Patrick CJ (1994) Emotion and psychopathy: startling new insights.Psychophysiol. 31, 319–330.CrossRefGoogle Scholar
  179. Patton JH, MS Stanford and ES Barratt (1995) Factor structure of the Barratt Impulsiveness Scale.J. Clin. Psychol. 51, 768–774.PubMedCrossRefGoogle Scholar
  180. Peluso MAM, JP Hatch, DC Glahn, ES Monkul, M Sanches, P Najt, CL Bowden, ES Barratt and JC Soares (2006) Trait impulsivity with mood disorders.J. Affect. Disord. 2006 Nov 8; [Epub ahead of print].Google Scholar
  181. Pencer A and J Addington (2003) Substance use and cognition in early psychosis.J. Psychiatr. Neurosci. 28, 48–54.Google Scholar
  182. Peterson L, A Thorup, P Jeppesen, J Oehlenschlager, T Christensen, M-B Abelet al. (2002) Substance harm and dependence in first-episode psychosis.Acta Psychiatr. Scand. 106 (Suppl 413), 22–35.Google Scholar
  183. Pierri JN, AS Chaudry, TU Woo and DA Lewis (1999) Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.Am. J. Psychiatry 156, 1709–1719.PubMedGoogle Scholar
  184. Plutchik R and HM van Praag (1995) The nature of impulsivity: definitions, ontology, genetics, and relations to aggression, In:Impulsivity and Aggression (Hollander E and DJ Stein, Eds.) (Wiley: New York), pp. 217–231.Google Scholar
  185. Potenza MN, MA Steinberg, P Skudlarski, RK Fulbright, CM Lacadie, MK Wilber, BJ Rounsaville, JC Gore and BE Wexler (2003) Gambling urges in pathological gambling: a functional magnetic resonance imaging study.Arch. Gen. Psychiatry 60, 828–836.PubMedCrossRefGoogle Scholar
  186. Potts GF, MRM George, LE Martin and ES Barratt (2006) Reduced punishment sensitivity in neural systems of behavior monitoring in impulsive individuals.Neurosci. Lett. 397, 130–134.PubMedCrossRefGoogle Scholar
  187. Poyurovsky M, P Dorfman-Etrog, H Hermesh, H Munitz, GD Tollefson and A Weizman (2000) Beneficial effect of olanzepine in schizophrenic patients with obsessive-compulsive symptoms.Int. Clin. Psychopharmacol. 15, 169–173.PubMedCrossRefGoogle Scholar
  188. Quednow BB, KU Kuhn, R Stelzenmueller, K Hoenig, W Maier and M Wagner (2004) Effects of serotonergic and noradrenergic antidepressants on auditory startle responses in patients with major depression.Psychopharmacology 175, 399–406.PubMedGoogle Scholar
  189. Raine A and F Jones (1987) Attention, autonomic arousal and personality in behaviorally disordered children.J. Abnorm. Child Psychol. 14, 583–599.CrossRefGoogle Scholar
  190. Raine A, MS Buchsbaum, J Stanley, S Lottenberg and AL Stoddard (1994) Selective reductions in prefrontal glucose metabolism in murderers.Biol. Psychiatry 36, 365–373.PubMedCrossRefGoogle Scholar
  191. Raine A, JR Meloy, S Bihrle, J Stoddard, L Lacasse and MS Buchsbaum (1998) Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers.Behav. Sci. Law 16, 319–332.PubMedCrossRefGoogle Scholar
  192. Raine A, T Lencz, S Bihrle, L LaCasse and P Colletti (2000) Reduced prefrontal grey matter volume and reduced autonomic activity in antisocial personality disorder.Arch. Gen. Psychiatry 57, 119–127.PubMedCrossRefGoogle Scholar
  193. Rasmussen SA and JL Eisen (1994) The epidemiology and differential diagnosis of obsessive compulsive disorder.J. Clin. Psychiatry 55, 5–10.PubMedGoogle Scholar
  194. Raust A, F Slama, F Mathieu, I Roy, A Chenu, D Koncke, D Fouques, F Jollant, E Jouvent, P Courtet, M Leboyer and F Belliver (2006) Prefrontal cortex dysfunction in patients with suicidal behavior.Psychol. Med. 37, 411–419.PubMedCrossRefGoogle Scholar
  195. Ray Li CS, SH Chen, WH Lin and YY Yang (2005) Attentional blink in adolescents with varying levels of impulsivity.J Psychiatr Res. 39(2), 197–205.PubMedCrossRefGoogle Scholar
  196. Reynolds B, A Örtengren and JB Richards (2006) Dimensions of impulsive behaviour: personality and behavioural measures.Pers. Individ. Differ. 40, 305–315.CrossRefGoogle Scholar
  197. Robbins TW (2005) Chemistry of the mind: neurochemical modulation of prefrontal cortical function.J. Comp. Neurol. 493, 140–146.PubMedCrossRefGoogle Scholar
  198. Robertson GS and HC Fibiger (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.Neuroscience 46, 315–328.PubMedCrossRefGoogle Scholar
  199. Robertson M (1987) Carbamazepine and depression.Int. J. Clin. Psychopharmacol. 2, 23–35.Google Scholar
  200. Rodriguez-Jimenez R, C Avila, MA Jimenez-Arriero, G Ponce, R Monasor, M Jimenez, M Aragues, J Hoenicka, G Rubio and T Palomo (2006) Impulsivity and sustained attention in pathological gamblers: influence of childhood ADHD history.J. Gambl. Stud. 22, 451–461.PubMedCrossRefGoogle Scholar
  201. Rotter JB (1966) Generalized expectancies for internal versus external control of reinforcement.Psychol. Monogr. 80, Nr. 609.Google Scholar
  202. Sacco KA, A Termine, A Seyal, MM Dudas, JC Vessicchio, S Krishnan-Sarin, PI Jatlow, BE Wexler and TP George (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.Arch. Gen. Psychiatry 62, 649–659.PubMedCrossRefGoogle Scholar
  203. Scarpe A and A Raine (1997) Psychophysiology of anger and violent behavior.Psychiatr. Clin. North Am. 20, 375–394.CrossRefGoogle Scholar
  204. Shih RA, PI Belmonte and PP Zandi (2004) A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders.Int. Rev. Psychiatry 16, 260–283.PubMedCrossRefGoogle Scholar
  205. Simeon D, E Hollander, DJ Stein, L Cohen and B Aronowitz (1995) Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.Am. J. Psychiatry 152, 1207–1209.PubMedGoogle Scholar
  206. Simpson MD, P Slater, JF Deakin, MC Royston and WJ Skan (1989) Reduced GABA uptake sites in the temporal lobe in schizophrenia.Neurosci. Lett. 107, 211–215.PubMedCrossRefGoogle Scholar
  207. Skodol AE and JM Oldham (1995) Phenomenology, differential diagnosis and comorbidity of the obsessive-compulsive spectrum disorder, In:Impulsivity and Aggression (Hollander E and DJ Stein, Eds.) (John Wiley and Sons: Sussex, UK), pp. 1–36.Google Scholar
  208. Soloff PH, CC Meltzer, C Becker, PJ Greer, TM Kelly and D Constantine (2003) Impulsivity and prefrontal hypometabolism in borderline personality disorder.Psychiatr. Res. 123, 153–163.CrossRefGoogle Scholar
  209. Someya T, K Sakado, T Seki, M Kojima, C Reist, SW Tang and S Takahashi (2001) The Japanese version of the Barratt Impulsiveness Scale, 11th version (BIS-11): its reliability and validity.Psychiatr. Clin. Neurosci. 55, 111–114.CrossRefGoogle Scholar
  210. Specker SM, GA Carlson, GA Christenson and M Marcotte (1995) Impulse control disoders and attention deficit disorder in pathological gamblers.Ann. Clin. Psychiatry 7, 175–179.PubMedCrossRefGoogle Scholar
  211. Spring B, R Pingitore and DE McChargue (2003) Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers.Am. J. Psychiatry 160, 316–322.PubMedCrossRefGoogle Scholar
  212. Stein DJ, RL Trestman, V Mitropoulou, EF Coccaro, E Hollander and LJ Siever (1996) Impulsivity and serotonergic function in compulsive personality disorder.J. Neuropsychiatr. Clin. Neurosci. 8 393–398.Google Scholar
  213. Stenberg G (1992) Personality and the EEG: arousal and emotional arousability.Pers. Individ. Differ. 13, 1097–1113.CrossRefGoogle Scholar
  214. Sterling J, Y Herzig, T Goren, N Finkelstein, D Lerner, W Goldenberg, L Miskolczi, S Molnar, F Rantalet al. (2002) Novel dual inhibitors of AchE and MAO derived from hydroxy aminoindan and phenylethylamine as potential treatment for Alzheimer’s disease.J. Med. Chem. 45, 5260–5279.PubMedCrossRefGoogle Scholar
  215. Stevens AA, PS Goldman-Rakic, JC Gore, RK Fulbright and BE Wexler (1998) Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging.Arch. Gen Psychiatry 55, 1097–1103.PubMedCrossRefGoogle Scholar
  216. Swann AC, JC Anderson, DM Dougherty and FG Moeller (2001) Measurement of inter-episode impulsivity in bipolar disorder.Psychiatr. Res. 101, 195–197.CrossRefGoogle Scholar
  217. Swann AC, P Pazzaglia, A Nicholls, DM Dougherty and FG Moeller (2003) Impulsivity and phase of illness in bipolar disorder.J. Affect. Disord. 23, 105–111.CrossRefGoogle Scholar
  218. Swann AC, DM Dougherty, P Pazzaglia, M Pham and FG Moeller (2004) Impulsivity: a link between bipolar disorder and substance abuse.Bipolar Disord. 6, 204–212.PubMedCrossRefGoogle Scholar
  219. Swann AC, DM Dougherty, P Pazzaglia, M Pham, JL Steinberg and FG Moeller (2005) Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder.Am. J. Psychiatry 162, 1680–1687.PubMedCrossRefGoogle Scholar
  220. Thompson RW and GT Nichols (1992) Correlations between scores on a continuous performancetest and parents/rs ratings of attention problems and impulsivity in children.Psychol. Rep. 70, 739–742.PubMedCrossRefGoogle Scholar
  221. Valdes IH, JL Steinberg, PA Narayana, LA Kramer, DM Dougherty, AC Swann, ES Barratt and FG Moeller (2006) Impulsivity and BOLD fMRI activation in MDMA-users and healthy control subjects.Psychiatr. Res.: Neuroimaging 147, 239–242.CrossRefGoogle Scholar
  222. Veazey C, SO Aki, KF Cook, EC Lai and ME Kunik (2005) Prevalence and treatment of depression in Parkinson’s disease.J. Neuropsychiatr. Clin. Neurosci. 17, 310–323.Google Scholar
  223. Vitacco MJ and R Rogers (2001) Predictors of adolescent psychopathy: the role of impulsivity, hyperactivity, and sensation seeking.J. Am. Acad. Psychiatr. Law 29, 374–382.Google Scholar
  224. Volk DW, JN Pierri, JM Fritschy, S Auh, AR Sampson and DA Lewis (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.Cereb. Cortex 12, 1063–1070.PubMedCrossRefGoogle Scholar
  225. Völlm BA, P Richardson, J Stirling, R Elliott, M Dolan, I Chaudry, C Del Ben, S McKie, I Anderson and B Deakin (2004) Neurobiological substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study.Crim. Behav. Ment. Health 14, 39–54.PubMedCrossRefGoogle Scholar
  226. Völlm BA, ANW Taylor, P Richardson, R Corcoran, J Stirling, S McKie, JFW Deakin and R Elliott (2006) Neuronal correlates of theory of mind and empathy: a functional magnetic imaging study in a nonverbal task.NeuroImage 29, 90–98.PubMedGoogle Scholar
  227. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.Psychopharmacology (Berl.)101, 431–447.CrossRefGoogle Scholar
  228. Weinstock M, T Goren and MBH Youdim (2000a) Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer’s disease, with cholinesterase and monoamine oxidase inhibitory activities.Drug Dev. Res. 50, 216–222.CrossRefGoogle Scholar
  229. Weinstock M, C Bejar, RH Wang, T Poltyrev, A Gross, JP Finberg and MBH Youdim (2000b) TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxides inhibitory activities for the treatment of Alzheimer’s disease.J. Neural Transm. 60, 157–169.Google Scholar
  230. Weizman A, R Weizman, C Fuchs, A Frisch and M Poyurovsky (2007) Comorbidity of schizophrenia and OCD: clinical aspects, neurobiology and treatment, In:Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebro y Mente: Madrid) (in press).Google Scholar
  231. Widiger TA (1991) DSM-IV reviews of the personality disorders: introduction to special series.J. Pers. Disord. 5, 122–134.Google Scholar
  232. Widiger TA (2005) Five factor model of personality disorder: integrating science and practice.J. Res. Pers. 39, 67–83.CrossRefGoogle Scholar
  233. Wirtshafter D and KE Asin (2003) Effects of haloperidol and clozapine on fos expression in the primate striatum.NeuroReport 14, 2429–2432.PubMedCrossRefGoogle Scholar
  234. Wu RM, RC Chen and CC Chiueh (2000) Effect of MAO-B inhibitors on MPP+ toxicityin vivo.Ann NY Acad. Sci. 899, 255–261.PubMedCrossRefGoogle Scholar
  235. Youdim MBH (2003) Rasagiline: an anti-Parkinson drug with neuroprotective activity.Exp. Rev. Neurother. 3, 737–749.CrossRefGoogle Scholar
  236. Youdim MBH and JJ Buccafusco (2005) Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders.Trends Pharmacol. Sci. 26, 27–35.PubMedCrossRefGoogle Scholar
  237. Youdim MBH and M Weinstock (2002) Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug, TV3326, [(N-Propargyl-(3R)Aminoindan-5-YL)-ethyl-methylcarbamate].Cell. Mol. Neurobiol. 21, 555–573.CrossRefGoogle Scholar
  238. Youdim MBH, A Gross and JPM Finberg (2001) Rasagiline [N-Propargyl-1R(+)-aminoindant], a selective and potent inhibitor of mitochondrial monoamine oxidase B.Br. J. Pharmacol. 132, 500–506.PubMedCrossRefGoogle Scholar
  239. Youdim MBH, W Maruyama and M Naoi (2005) Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline.Drugs Today 41, 369–391.PubMedCrossRefGoogle Scholar
  240. Youdim MBH, T Amit, BO Weinreb and M Yogev-Falach (2006) Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs: ladostigil.Neurotox. Res. 10, 1–11.Google Scholar
  241. Ziedonis DM and K Trudeau (1997) Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model.Schizophr. Bull. 23, 229–238.PubMedGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Tomas Palomo
    • 1
  • Richard M. Kostrzewa
    • 2
  • Richard J. Beninger
    • 3
  • Trevor Archer
    • 4
    • 5
  1. 1.Psychiatry Service, “12 de Octubre”University HospitalMadridSpain
  2. 2.Department of Pharmacology, Quillen College of MedicineEast Tennessee State UniversityJohnson CityUSA
  3. 3.Departments of Psychology and PsychiatryQueen’s UniversityKingstonCanada
  4. 4.Department of PsychologyUniversity of GöteborgGöteborg
  5. 5.HBVUniversity of KalmarKalmarSweden

Personalised recommendations